OVARIAN SERTOLI-LEYDIG CELL TUMOUR

OVARIAN SERTOLI-LEYDIG CELL TUMOUR was reported 8 times

OVARIAN SERTOLI-LEYDIG CELL TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 2 0.0009
1 Alkylating Drug [EPC] 4 0.0000
2 Interleukin-23 Antagonist [EPC] 1 0.0000
3 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
5 Platinum-based Drug [EPC] 1 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
7 Thalidomide Analog [EPC] 1 0.0000
8 Proton Pump Inhibitor [EPC] 1 0.0000
9 Corticosteroid [EPC] 1 0.0000
10 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000